Sacrospinous Ligament Fixation vs Ischial Spine Fascia Fixation

NCT ID: NCT03005613

Last Updated: 2019-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Investigational intervention:SSLF or ISFF operations

Study title:A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation.

Principal Investigator:Chang Ren, M.D., Department of Obstetrics \& Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences \& Peking Union Medical College.

Study subjects:Adult patients with symptomatic stage II\~IV pelvic organ prolapse will be eligible if all the inclusion criteria are met and without any reason for exclusion.

Study objectives:The primary objective of this study is to assess the short and mid-term efficacy of Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation in treating stage II\~ IV pelvic organ prolapse and their recurrence rate as well as their impacts on quality of life.

Study design:Prospective, Single-Blind, Randomized, Clinical Trial

Intervention:

* ISFF group:Patients receive ISFF according to randomization.
* SSLF group:Patients receive SSLF according to randomization

Sample size:76 patients (38 in ISFF group, 38 in SSLF group)

Primary endpoint:

•objective success rates at 3 months after operations.

Secondary endpoints:

* peri-operative parameters .
* subjective satisfactory rates at 1 year after operations
* quality of life questionnaires at 1 year after operations

Safety endpoints: complications

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urogenital Prolapse

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Pelvic organ prolapse Sacrospinous ligament fixation Ischial spine fascia fixation Clinical outcome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

sacrospinous ligament fixation group

The patients will receive sacrospinous ligament fixation operation.

Group Type ACTIVE_COMPARATOR

sacrospinous ligament fixation

Intervention Type PROCEDURE

The participants will receive sacrospinous ligament fixation.

ischial spine fascia fixation group

The patients will receive ischial spine fascia fixation operation.

Group Type EXPERIMENTAL

ischial spine fascia fixation

Intervention Type PROCEDURE

The participants will receive ischial spine fascia fixation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ischial spine fascia fixation

The participants will receive ischial spine fascia fixation.

Intervention Type PROCEDURE

sacrospinous ligament fixation

The participants will receive sacrospinous ligament fixation.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age≤65 years, for those scheduled to receive hysterectomy age≥40 years
* patients with symptomatic stage II\~IV uterine or vaginal vault prolapse
* receiving SSLF or ISFF in the gynecological department at Peking Union Medical College Hospital

Exclusion Criteria

* plans to live abroad within follow-up span
* contradiction to these two operations: acute genital infection, narrow vagina (less than two finger-breadth), too-ill to receive operations
* patients with hip joint problem who could not pose a lithotomy position
Minimum Eligible Age

25 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking Union Medical College Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chang Ren, M.D.

Role: PRINCIPAL_INVESTIGATOR

Peking Union Medical College Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Ob & Gyn, Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chang Ren, M.D.

Role: CONTACT

Phone: +86-134-886-988-61

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chang Ren, M.D.

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Dwyer PL, Lee ET, Hay DM. Obesity and urinary incontinence in women. Br J Obstet Gynaecol. 1988 Jan;95(1):91-6. doi: 10.1111/j.1471-0528.1988.tb06486.x.

Reference Type BACKGROUND
PMID: 3342213 (View on PubMed)

Sze EH, Karram MM. Transvaginal repair of vault prolapse: a review. Obstet Gynecol. 1997 Mar;89(3):466-75. doi: 10.1016/S0029-7844(96)00337-7.

Reference Type BACKGROUND
PMID: 9052607 (View on PubMed)

Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997 Apr;89(4):501-6. doi: 10.1016/S0029-7844(97)00058-6.

Reference Type BACKGROUND
PMID: 9083302 (View on PubMed)

Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010 Nov;116(5):1096-100. doi: 10.1097/AOG.0b013e3181f73729.

Reference Type BACKGROUND
PMID: 20966694 (View on PubMed)

Boyles SH, Weber AM, Meyn L. Procedures for pelvic organ prolapse in the United States, 1979-1997. Am J Obstet Gynecol. 2003 Jan;188(1):108-15. doi: 10.1067/mob.2003.101.

Reference Type BACKGROUND
PMID: 12548203 (View on PubMed)

Barber MD, Maher C. Apical prolapse. Int Urogynecol J. 2013 Nov;24(11):1815-33. doi: 10.1007/s00192-013-2172-1.

Reference Type BACKGROUND
PMID: 24142057 (View on PubMed)

Jones KA, Shepherd JP, Oliphant SS, Wang L, Bunker CH, Lowder JL. Trends in inpatient prolapse procedures in the United States, 1979-2006. Am J Obstet Gynecol. 2010 May;202(5):501.e1-7. doi: 10.1016/j.ajog.2010.01.017. Epub 2010 Mar 11.

Reference Type BACKGROUND
PMID: 20223444 (View on PubMed)

Zhu L, Lang J, Zhang Q. Clinical study of ischia spinous fascia fixation--a new pelvic reconstructive surgery. Int Urogynecol J. 2011 Apr;22(4):499-503. doi: 10.1007/s00192-010-1307-x.

Reference Type BACKGROUND
PMID: 21060988 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC-H0407-8160061244

Identifier Type: -

Identifier Source: org_study_id